Admission and Introduction of Company Shares to Trading on Main Market of WSE

6 February 2025

Subject: Admission and Introduction of Company Shares to Trading on Main Market of WSE

Legal basis: Article 56 of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading, and Public Companies of 29 July 2005

Text of the report:

1. The Management Board of Diagnostyka S.A. (the “Company”) hereby announces that on 6 February 2025, it received:
   Resolution No. 128/2025 of the Warsaw Stock Exchange (the “WSE”), dated 6 February 2025, whereby the WSE Management Board decided to admit 17,825,553 Series D, Series E and Series F ordinary bearer shares in the Company, with a par value of PLN 1.00 each (“Shares”), to trading on the main market of the WSE; and
2. Resolution No. 129/2025 of the WSE, dated 6 February 2025, whereby the WSE Management Board decided to introduce the Shares to trading on the main market of the WSE. The first trading day has been set for 7 February 2025.

The Shares will be listed in the continuous trading system under the abbreviated name “DIAG” and ticker symbol “DIA”.
Following admission of the Shares to trading on the WSE, the Company has become a “public company” within the meaning of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading, and Public Companies of 29 July 2005 (the “Act”), and is consequently required to publicly disclose current and periodic information within statutorily prescribed time limits and in accordance with applicable laws and regulations, including, without limitation, the provisions of the Act and any subordinate legislation promulgated thereunder.

Specific legal basis: Section 17.1.2 and Section 17.1.4 of the Minister of Finance’s Regulation on current and periodic information to be published by issuers of securities and conditions for recognition as equivalent of information whose disclosure is required under the laws of a non-member state of 29 March 2018

For the Company:
Paweł Chytła – Vice President of the Management Board
Jaromir Pelczarski – Vice President of the Management Board